-
Desert King® Becomes First Chilean Company to Earn EXCiPACT™ Certification, Cementing Global Leadership in Vaccine Adjuvant Production
Desert King®, a global leader in Quillaja saponaria-based vaccine adjuvants, has secured EXCiPACT™ certification for its Chilean pharmaceutical facility, becoming the first Chilean company and only global Quillaja supplier to…
-
QS-21: A Potent Vaccine Adjuvant
QS-21 is one of the active fractions of the bark of Chilean tree, Quillaja saponaria, purified using a reverse-phase chromatography (RP-HPLC).QS denotes its source as Q. saponaria and the number…
-
The Second Online Scientific Forum on Novel Vaccine Adjuvants
Vuroyal will hold the 2nd Online Technology Forum on Novel Vaccine Adjuvants on April 19, 2025 from 09:00am-11:30pm CET, focusing on the research process, clinical application, and related review submissions…
-
The DesertKing producing QS-21 and Vet-Sap became the excipients company certified by IPEC GMP
The Desert King International, which devotes itself to support the production of adjuvant excipients for human vaccines and animal-protected vaccines, has recently been certified as a GMP-compliant manufacturer by the…
-
Oxford-Serum Institute Malaria Vaccine R21/Matrix-M™ Named 2024 Breakthrough of the Year: QS-21 Powered Success
Malaria infects hundreds of millions and claims over 600,000 lives annually. Despite decades of global research, vaccine development faced persistent challenges due to ineffective adjuvants. The breakthrough came when Novavax…
-
QS-21 Forum
VuRoyal & Desert King International Event Agenda (March 20–23, 2024) On March 20, 2024, vuRoyal and Desert King International will jointly organize the first QS-21 Forum in Shanghai, China. The…
Author: yizhang
No comments to show.